CRIS, Curis (formerly CBMI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI)

CRIS 1.480

0.0%

11:48 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (603)	5/10/2007 12:52:56 PM
From: Jim Oravetz	Read Replies (1) of 668

Procter & Gamble Ends Collaboration Pact With Curis DOW JONES NEWSWIRES May 10, 2007 12:38 p.m. Curis Inc. (CRIS) said Thursday that Procter & Gamble Inc. (PG) has ended a research-and-license agreement with the company. Curis, of Cambridge, Mass., said Procter & Gamble ended the pact because it believes one of the compounds Curis was developing didn't "exhibit an acceptable safety profile to warrant further development," according to a filing with the Securities and Exchange Commission. The consumer-products giant notified Curis on Wednesday that it was ending the agreement, but the termination won't take effect until November. At that time, all licenses granted Procter & Gamble by Curis will terminate.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next